RANI Earnings

RANI reported its FY2025Q3 earnings on 2025-11-06, showcasing a revenue of against an estimate of 10.00M, resulting in a 0% surprise. The EPS was -0.12, surpassing the expected -0.09 by -33.33%. The stock experienced a -11.01% price change on the earnings day and a -6.61% change over the next five days, reflecting market reactions to the results.

Following RANI's FY2025Q3 earnings announcement on 2025-11-06, the stock price moved by -11.01% on the day of the release. Over the subsequent five days, it saw a -6.61% change. Historically, RANI's stock price tends to shift by an average of 15.13% in the 10 days leading up to earnings and -3.5% in the 10 days following, providing insight into potential market.

For , analysts estimate RANI's annual revenue to reach , while the EPS is projected at -0.07. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between RANI's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, RANI's stock price typically moves by 15.13% in the 10 days before its earnings and -3.5% in the 10 days after. For the upcoming earnings, analysts expect an EPS of -0.07 and revenue of .

The earnings call reveals significant challenges: a decrease in cash reserves, operational cost constraints, and an impairment loss. The lack of a share repurchase program and competitive pressures also weigh negatively. While there is interest in the RaniPill and a focus on RT-114, the lack of clear guidance on costs and capital constraints suggest potential struggles. The overall sentiment from the Q&A is cautious, with concerns about financial health and competitive positioning. These factors suggest a negative stock price movement in the short term.